跳至主要内容
临床试验/CTRI/2017/01/007670
CTRI/2017/01/007670已完成未知

A prospective,open label,two arm clinical study to evaluate the efficacy and safety of C3 Reduct ODN in the treatment of canker sore and gingivitis.

Sami Labs Limited0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Healthy male and or female with no systemic disease.
  • 2 Age between 18 to 60 years.
  • 3 Having mouth ulcers with throat pain or Patients with mild to moderate gingivitis.
  • 4 Patients having erupted teeth.
  • 5 Willing to come for regular follow-up visits.
  • 6 Able to give written informed consent.

排除标准

  • 2 Presence of any systemic hematological problems.
  • 3 Drug or alcohol abuse.
  • 4 Under systemic or topical corticosteroid therapy.
  • 5 Pregnant women or lactating mothers
  • 6 History of HIV and other viral infections.
  • 7 History of any antibiotic therapy in past 3 months.
  • 8 History of oral prophylaxis within 6 months previous to the study
  • 9 Patients with mouth breathing habit.
  • 10 Patients using orthodontic and prosthodontics appliances
  • 11 Are on analgesics or antiseptics.
  • 12 Patients who have received any periodontal therapy in the past 6 months.

研究者

发起方
Sami Labs Limited

相似试验